Map of Pancreatica Walks and Runs

Category Archives: Pancreatic Cancer Medical Treatment

Adjustments to the FOLFIRINOX Combination for Improved Tolerability in Pancreatic Cancer

Since the May 12, 2011 New England Journal of Medicine article that reported the possible superiority of the 5-FU based four-drug FOLFIRINOX regimen over gemcitabine in the treatment of metastatic pancreatic cancer (and subsequent FDA approval), researchers have been at work trying to discover the best use of this information – and ways to perhaps […]

Share Button

Cancer Diversity: Enemy of Personalized Medicine ?

In what appears to be a season of blockbuster conceptual research results in the cancer medical literature, comes a recent study involving leukemia cells but which has implications for the entire spectrum of cutting edge cancer treatment. The general current prevailing thought on the origin of cancer is that a pattern of gene mutations or […]

Share Button

Biomarker miR-10b for Cancer of the Pancreas: earlier diagnosis and/or therapeutic target?

As alluded to in another recent blog entry, the study of microRNA has been a source of great interest as to the possible development of biomarkers that may screen or aid on the diagnosis of pancreatic cancer.  MicroRNAs (or sometimes abbreviated miR) are small (18 to 25 nucleotide) non-coding RNA molecules that are involved in […]

Share Button
Page 5 of 8« First...34567...Last »